The Body PRO
The 4th Conference on Retroviruses and Opportunistic Infections
Washington, D.C.
January 16, 1997
This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.
Funding for this conference coverage at The Body is provided, in part, through an unrestricted educational grant by Bristol-Myers Squibb Immunology.
Conference Reports From Drs. Torres and Pavia
Conference-Related Articles
Combination Studies:
Protease Inhibitors:
"What's New" -- New Drugs in the Pipeline:
Women and Perinatal Studies:
Effects of New Treatment Therapies:
Opportunistic Infections:
Other Topics:
This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.
This article was provided by
The Body PRO.
It is a part of the publication The 4th Conference on Retroviruses and Opportunistic Infections.
